Liver Cirrhosis
Mesenchymal Stem Cells (MSCs) are being studied in liver cirrhosis to explore whether their regenerative and immune-modulating properties may help support liver health. Current research evaluates biological signals such as anti-fibrotic activity and tissue repair.
Liver cirrhosis is a progressive condition caused by long-term liver damage, often due to hepatitis, alcohol use, or metabolic disease. It leads to scarring, impaired function, and can progress to failure where transplantation remains the only curative option.
Although findings are early, MSC investigations are expanding the scientific understanding of potential cell-based approaches in hepatology and regenerative medicine.
Clinical Trials